Risk factors for failing to complete gemcitabine–cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients
Investigative and Clinical Urology · 2024
DOI: 10.4111/icu.20230389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative and Clinical Urology, 2024. Verfasst von Homin Kang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cisplatin, Gemcitabine, Deoxycytidine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. lbj1986@hanmail.net.
ORCID-Profile: Homin Kang, Jungyo Suh, Dalsan You, In Gab Jeong, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn, Bumjin Lim
Zitieren
APA
Kang, H., Suh, J., You, D., Jeong, I. G., Hong, B., Hong, J. H., Ahn, H., & Lim, B. (2024). Risk factors for failing to complete gemcitabine–cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients. Investigative and Clinical Urology. https://doi.org/10.4111/icu.20230389
Vancouver
Kang H, Suh J, You D, Jeong IG, Hong B, Hong JH, et al. Risk factors for failing to complete gemcitabine–cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients. Investigative and Clinical Urology. 2024. doi:10.4111/icu.20230389
BibTeX
@article{Kang2024,
author = {Kang, Homin and Suh, Jungyo and You, Dalsan and Jeong, In Gab and Hong, Bumsik and Hong, Jun Hyuk and Ahn, Hanjong and Lim, Bumjin},
title = {Risk factors for failing to complete gemcitabine–cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients},
journal = {Investigative and Clinical Urology},
year = {2024},
doi = {10.4111/icu.20230389}
}
EUVIMED